Pharma Groups, Economists Knock Effexor Antitrust Appeal

By Jeff Zalesin (February 24, 2016, 8:23 PM EST) -- A group of economists and two pharmaceutical industry groups on Tuesday warned that if the Third Circuit revives antitrust claims against Wyeth LLC and Teva Pharmaceutical Industries Ltd. over their patent settlement involving the antidepressant Effexor XR, it could relax the pay-for-delay pleading standard too much and deter beneficial agreements....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!